UF Innovate Ventures is the University of Florida’s $1 million annual pre-seed and seed-stage venture fund that invests exclusively. See contact routes.
UF Innovate Ventures is the University of Florida’s $1 million annual pre-seed and seed-stage venture fund that invests exclusively in startups founded on licensed UF intellectual property, with check sizes typically ranging from $200,000 to $500,000. The firm co-invests alongside institutional venture capitalists rather than leading deals, focusing on sectors aligned with UF research strengths including life sciences, agricultural technology, AI/ML, and industrial tech. Notable portfolio companies include Abfero Pharmaceuticals (retinal/neurological drug development), Atensa Therapeutics (gene therapy for blindness), TearClear (ophthalmic pharmaceuticals), and Entrinsic Health Solutions (hydration science from UF peptide research). Its distinctive thesis mandates that every investment must be a UF spinout with licensed technology, functioning as launch capital before companies pursue external Series A rounds.
Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Florida.
Investors like UF Innovate Ventures · Full investor directory · Investor access · Company funding database